Baseline NT-proBNP and responsiveness to autonomic regulation therapy in patients with heart failure and reduced ejection fraction.

Anand, Inder; Ardell, Jeffrey L; Gregory, Doug; Libbus, Imad; DiCarlo, Lorenzo; Premchand, Rajendra K; Sharma, Kamal; Mittal, Sanjay; Monteiro, Rufino

Anand, Inder; Ardell, Jeffrey L; Gregory, Doug; Libbus, Imad; DiCarlo, Lorenzo; Premchand, Rajendra K; Sharma, Kamal; Mittal, Sanjay; Monteiro, Rufino.

Anand I; University of Minnesota (Emeritus), Minneapolis, MN, USA.
Ardell JL; University of California Los Angeles, Los Angeles, CA, USA.
Gregory D; Clinical Cardiovascular Science Foundation, Boston, MA, USA.
Libbus I; LivaNova USA, Inc., Houston, TX, USA.
DiCarlo L; LivaNova USA, Inc., Houston, TX, USA.
Premchand RK; Krishna Institute of Medical Sciences, Secunderabad, India.
Sharma K; Sanjivani Super Specialty Hospitals, Ahmedabad, India.
Mittal S; Medanta, The Medicity, Haryana, India.
Monteiro R; Vintage Hospital, Goa, India.

Int J Cardiol Heart Vasc ; 29: 100520, 2020 Aug.

Article en En | MEDLINE | ID: mdl-32509959

Palabras clave

Autonomic regulation therapy; Baroreceptor activation therapy (BAT); Carotid nerve plexus stimulation; Guideline directed medical therapy (GDMT); Heart failure; N-terminal pro-brain natriuretic peptide (NT-proBNP); Neuromodulation; Vagus nerve stimulation (VNS)

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2020 Tipo del documento: Article